Brain-boosting Molecular Trigger Found Using Electrical Stimulation
March 2, 2024 10:04 am | by Bevin Fletcher, Associate Editor | News | CommentsThe Office of Naval Research (ONR) Global sponsored a new mouse study that has the potential to advance the way people learn and make connections.
Would You Trust a Robot in a Burning Building?
March 2, 2024 9:58 am | by Greg Watry, Digital Reporter | News | CommentsResearchers put 42 participants through an experiment—giving them a choice to trust a robot in a time of emergency or go with their intuition. Which one did most choose?
_itok-8Xc6pQqt.jpg)
Utilization of the Crowd for Medical Research
March 2, 2024 9:09 am | by Sujay Jadhav, CEO, goBalto | Articles | CommentsRecently, some have begun to explore the utilization of the crowd for various purposes in medical research, including fundraising as well as crowdsourcing for intellectual analyses and insights.
Potential Huntington’s Treatment Successful in Animals, Moves to Clinical Testing
March 1, 2024 9:50 am | by Bevin Fletcher, Associate Editor | News | CommentsA new drug that treats the underlying cause of Huntington’s disease has been shown to be effective and safe in mice and monkeys, and a Phase 1/2a clinical human trial has begun.
Precision Medicine Prevents Common Cardiovascular Disease in Mice
February 29, 2024 9:41 am | by Bevin Fletcher, Associate Editor | News | CommentsA new precision medicine approach to cardiovascular disease has been proven effective in mice and a Phase 1 human clinical trial is underway.
Bioscience Bulletin: TB Blood Test, J&J Pays $72M, and a Potential Treatment for Fatty Liver Disease
February 26, 2024 2:56 pm | by Bevin Fletcher, Associate Editor | News | CommentsCheck out our top stories this week!
HPV Vaccine Working, CDC Says
February 26, 2024 11:18 am | by Seth Augenstein, Digital Reporter | News | CommentsThe HPV vaccine, introduced about a decade ago, is working at a population level to beat back the most common sexually transmitted infection, according to a new CDC study.
J&J to Pay $72M for Cancer Death Linked to Talcum Powder
February 25, 2024 10:33 am | by Seth Augenstein, Digital Reporter | News | CommentsJohnson & Johnson will pay $72 million in damages to the surviving family members of a woman who died from ovarian cancer that was linked to the company’s talcum powder products.
Cuban Lung Cancer Vaccine Could be Coming
February 25, 2024 10:25 am | by Seth Augenstein, Digital Reporter | News | CommentsPresident Obama’s visit to Cuba next month is the first by an American president in nearly a century. The thawing relations between the two countries could bring a lung cancer vaccine to the U.S. that has been available in Cuba since 2011.
Michael J. Fox Foundation Partners with Charles River Laboratories on Parkinson’s Research
February 25, 2024 9:56 am | by Bevin Fletcher, Associate Editor | News | CommentsThe Michael J. Fox Foundation, an organization devoted to supporting the diagnosis and treatment of Parkinson’s disease, has expanded its collaboration with contract research organization, Charles River Laboratories. The two are working together to investigate mutations in the LRRK2 gene, which are the greatest known genetic causes of Parkinson’s disease (PD).
Newly Discovered Gene Links Sleep and Seasonal Affective Disorder
February 24, 2024 9:33 am | by Bevin Fletcher, Associate Editor | News | CommentsA study from University of California, San Francisco investigates a new gene mutation that is linked both to seasonal depression and uncommon sleep problems.
Q&A with Axol Bioscience’s New CSO
February 23, 2024 9:09 am | by Bevin Fletcher, Associate Editor | News | CommentsBioscience Technology chatted with Xianmin Zeng, Ph.D., associate professor at the Buck Institute for Research on Aging, about her move to industry as she takes on a new role as Chief Scientific Officer for Axol Bioscience.
Bioscience Bulletin: E-cigarette Findings, and Marijuana and Memory Problems
February 23, 2024 9:07 am | by Bevin Fletcher, Associate Editor | News | CommentsCheck out our top stories this week!
Finding the Information ‘Needle in a Haystack’
February 19, 2024 11:07 am | by Laurent Fanichet, Vice President of Marketing, Sinequa | Articles | CommentsDigging through volumes of pharmaceutical data in any form, be that of lab reports, experimental results, clinical trial reports, scientific publications, patent filings, to even emails is a gargantuan task. The data may deal with diseases, genes, drugs, active agents and mechanisms of action and can be textual, structured data like molecule structures, formulae, SAS data sets from clinical trials, curves, diagrams, and more.
Common Antibiotics May be Associated with Delirium
February 19, 2024 10:53 am | by Bevin Fletcher, Associate Editor | News | CommentsAntibiotics are a common prescription for infection, but new research investigates a link to temporary mental confusion, known as delirium, and other brain problems that may be stronger than previously thought.
_itok-_ZKZ1JK-.jpg)
Vaccine Against Opioid Addiction and Overdose Successful in Mice
February 18, 2024 10:55 am | by Bevin Fletcher, Associate Editor | News | CommentsFentanyl, a highly potent opioid that has been showing up in heroin, may have a new barrier – a vaccine developed by researchers at The Scripps Research Institute that keeps the drug from reaching the brain and protects from lethal overdoses.
Mouse Rage Can be Turned On and Off with Brain Probe
February 17, 2024 9:26 am | by Seth Augenstein, Digital Reporter | News | CommentsViolent rage can be a survival mechanism. But the brain wiring behind it is still little understood. But a select group of brain cells have been identified the “gatekeepers” of the cascade of runaway rage in some male mice, according to a new study.
AbbVie Joins Dementia Consortium
February 17, 2024 9:09 am | by Bevin Fletcher, Associate Editor | News | CommentsPharmaceutical company AbbVie is the latest member to join the Dementia Consortium, a global collaboration seeking to advance development of research and treatments for the condition.
One Test Looks to Identify Ebola, Zika, and More
February 17, 2024 9:00 am | by Bevin Fletcher, Associate Editor | News | CommentsA scientist from the University of California, San Francisco is looking to change the way we diagnose and get ahead of infectious diseases, such as Ebola, Zika and chikungunya.
Extended Marijuana Use Linked to Memory Problems Later
February 16, 2024 10:17 am | by Bevin Fletcher, Associate Editor | News | CommentsA new study from researchers at the University of California, San Francisco found that “mid-level” marijuana users, who used pot for a cumulative of five years performed worse on verbal memory tests but did not have trouble in other areas of cognitive function.
Bioscience Bulletin: Deer with Malaria, MERS Autopsy, and No More BMI
February 12, 2024 3:40 pm | by Bevin Fletcher, Associate Editor | News | CommentsCheck out our top stories this week!
New Device Could Enable Brain Control of Exoskeletons
February 12, 2024 9:01 am | by Bevin Fletcher, Associate Editor | News | CommentsThe device that may someday give people with spinal cord injuries the ability to walk just by thinking, is the size of a matchstick and can be implanted into a blood vessel in the brain without the need for invasive surgery.
Poor Fitness May Affect Brain Volume Decades Later
February 11, 2024 9:44 am | by Bevin Fletcher, Associate Editor | News | CommentsMore evidence for the benefits of physical fitness comes to light in a new Neurology study that found an association between lack of exercise in mid-life and smaller brain size 20 years later.
Cotton Candy Machine Could Lead to the Creation of Artificial Organs
February 10, 2024 9:35 am | by Bevin Fletcher, Associate Editor | News | CommentsAn unlikely tool is behind a new technique that could someday lead to the creation of life-sized artificial livers, kidneys and other essential organs: a cotton candy machine.
Mayo Clinic Team Finds Another Species of Lyme Bacteria
February 10, 2024 9:34 am | by Seth Augenstein, Digital Reporter | News | CommentsMayo Clinic scientists say they have found a new species of bacteria causing Lyme disease in the Midwest, with elevated levels of bacteria in the blood.
- Page 1
- Next
